References
- Kahn RS, Sommer IE, Murray RM, et al. Schizophrenia. Nat Rev Dis Primers. 2015;1:15067.
- Desai P, Lawson K, Barner J, et al. Estimating the direct and indirect costs for community-dwelling patients with schizophrenia. J Pharm Health Serv Res. 2013;4(4):187–194.
- Wu EQ, Shi L, Birnbaum H, et al. Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approach. Psychol Med. 2006;36(11):1535–1540.
- Bhugra D. The global prevalence of schizophrenia. PLoS Med. 2005;2(5):e151.
- Centers for Medicare & Medicaid Services (CMS). Physical and mental health condition prevalence and comorbidity among fee-for-service Medicare–Medicaid enrollees. Baltimore (MD): CMS; 2014. p. 1–84.
- Cloutier M, Aigbogun MS, Guerin A, et al. The economic burden of schizophrenia in the United States in 2013. J Clin Psychiatry. 2016;77(6):764–771.
- Fitch K, Iwasaki K, Villa KF. Resource utilization and cost in a commercially insured population with schizophrenia. Am Health Drug Benefits. 2014;7(1):18–26.
- National Institute of Mental Health. Schizophrenia. 2018 [cited 2020 Apr 7]. Available from: https://www.nimh.nih.gov/health/statistics/schizophrenia.shtml#part_154880
- Buckley PF, Miller BJ, Lehrer DS, et al. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35(2):383–402.
- Austin PC. Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research. Commun Stat – Simul Comput. 2009;38(6):1228–1234.
- Tien AY, Eaton WW. Psychopathologic precursors and sociodemographic risk factors for the schizophrenia syndrome. Arch Gen Psychiatry. 1992;49(1):37–46.
- Bartels SJ, Clark RE, Peacock WJ, et al. Medicare and Medicaid costs for schizophrenia patients by age cohort compared with costs for depression, dementia, and medically ill patients. Am J Geriatr Psychiatry. 2003;11(6):648–657.
- Andrews AO, Bartels SJ, Xie H, et al. Increased risk of nursing home admission among middle aged and older adults with schizophrenia. Am J Geriatr Psychiatry. 2009;17(8):697–705.
- Miller EA, Rosenheck RA. Risk of nursing home admission in association with mental illness nationally in the Department of Veterans Affairs. Med Care. 2006;44(4):343–351.
- Harvey PD, Loewenstein DA, Czaja SJ. Hospitalization and psychosis: influences on the course of cognition and everyday functioning in people with schizophrenia. Neurobiol Dis. 2013;53:18–25.
- Nicholl D, Akhras KS, Diels J, et al. Burden of schizophrenia in recently diagnosed patients: healthcare utilisation and cost perspective. Curr Med Res Opin. 2010;26(4):943–955.
- Amminger GP, Henry LP, Harrigan SM, et al. Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-term follow-up study. Schizophr Res. 2011;131(1–3):112–119.
- Kane JM, Robinson DG, Schooler NR, et al. Comprehensive versus usual community care for first-episode psychosis: 2-year outcomes from the NIMH RAISE early treatment program. Am J Psychiatry. 2016;173(4):362–372.
- Ruggeri M, Bonetto C, Lasalvia A, et al. Feasibility and effectiveness of a multi-element psychosocial intervention for first-episode psychosis: results from the cluster-randomized controlled GET UP PIANO trial in a catchment area of 10 Million inhabitants. Schizophr Bull. 2015;41(5):1192–1203.
- Rosenheck R, Leslie D, Sint K, et al. Cost-effectiveness of comprehensive, integrated care for first episode psychosis in the NIMH RAISE early treatment program. Schizophr Bull. 2016;42(4):896–906.